Panthagani, Jesse
O’Donovan, Charles http://orcid.org/0000-0003-4416-5037
Aiyegbusi, Olalekan Lee
Liu, Xiaoxuan
Bayliss, Susan
Calvert, Melanie http://orcid.org/0000-0002-1856-837X
Pesudovs, Konrad
Denniston, Alastair K. http://orcid.org/0000-0001-7849-0087
Moore, David J. http://orcid.org/0000-0002-4163-4080
Braithwaite, Tasanee http://orcid.org/0000-0002-3025-4066
Article History
Received: 31 August 2022
Revised: 9 January 2023
Accepted: 28 February 2023
First Online: 17 March 2023
Competing interests
: MC is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for the Centre for Patient Reported Outcomes Research and is a National Institute for Health and Care Research (NIHR) Senior Investigator. MC receives funding from the NIHR Birmingham Biomedical Research Centre, NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR Birmingham-Oxford Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, and NIHR ARC West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UK Research and Innovation), Macmillan Cancer Support, SPINE UK,UKRI, UCB Pharma, Janssen, GSK and Gilead. MC has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work. OLA receives funding from the NIHR Birmingham Biomedical Research Centre (BRC), NIHR Applied Research Collaboration (ARC), West Midlands, NIHR Birmingham-Oxford Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics at the University of Birmingham and University Hospitals Birmingham NHS Foundation, Innovate UK (part of UK Research and Innovation), Gilead Sciences Ltd, Janssen pharmaceuticals, Inc, and Sarcoma UK. OLA declares personal fees from Gilead Sciences Ltd, GlaxoSmithKline (GSK) and Merck outside the submitted work. The authors have no competing interests